Developer docs
API playgroundTry for free, no card

Search company profiles

larc robotics

Full company profile

uuid02mlih1

Namestring
larc robotics
Legal namestring
LARC Robotics LLC
Company typeenum
Private
Founded yearstring
-
Descriptiontext

LARC Robotics LLC is a privately held medical device company headquartered at 535 5th Ave 4th floor in New York, NY, that develops the LARC Robot, a table-mounted miniature surgical robotic platform designed specifically for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures used to treat kidney stones. The platform combines intraoperative planning, real-time imaging targeting, and robotic-assisted needle insertion, and is CE-marked and FDA-cleared for both 2D and 3D image-guided procedures. Its primary value proposition is enabling urologists to perform renal access independently without reliance on interventional radiologists, addressing technical complexity, operative time, radiation exposure, and scheduling dependencies that the company cites as the main drivers of PCNL's roughly 7% adoption rate among kidney stone procedures.

The company is a spin-off of Austria-based Interventional Systems and operates as part of the iSYS Medizintechnik GmbH group, inheriting domain expertise and product know-how in interventional radiology. Its commercial model is a direct-sales approach to hospitals and healthcare facilities performing urology procedures, consistent with enterprise capital-equipment procurement; pricing is not publicly disclosed and is presumed to be quote-based. GTM channels are predominantly clinical-scientific in nature, including LinkedIn, Twitter, YouTube (surgical session and conference content), email newsletters, and industry-conference presentations such as LSI Europe 2024.

The product roadmap extends the single hardware product with planned 2D-fluoroscopic navigation and ultrasound guidance support, a digital platform for patient-specific 3D reconstructions of diagnostic scans, and a post-procedural data and analytics module. The company is GDPR-compliant, maintains a small public footprint, and has no disclosed revenue, headcount, funding rounds, or named hospital customers in the source material.

Short descriptiontext

LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic platform for image-guided renal access during percutaneous nephrolithotomy (PCNL) kidney stone procedures, serving urologists and hospitals.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical robotics systems, image-guided surgery, renal access devices, percutaneous nephrolithotomy equipment, medical robotics platform
Industry2 codes
1Surgical Robotics & Computer-Assisted Surgery Platforms
CodeHLAHADAFPrimaryYes
2Healthcare & Assistive Robotics
CodeHDAAAIACPrimaryNo
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Surgical Robotics
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic device designed for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures. The platform combines intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion to allow urologists to independently establish renal access for kidney stone removal without relying on interventional radiologists. The technology is cleared for both 2D and 3D image-guided procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • PCNL is the technique with the highest stone-free rate and best chance for single-surgery treatment
+1 more record
Product overview1 text field

LARC Robotics offers a single unified surgical robotic platform called the LARC Robot, designed specifically for percutaneous nephrolithotomy (PCNL) procedures to treat kidney stones. The platform is a table-mounted miniature device that provides intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion. The company is also developing future capabilities including 2D-fluoro navigation and ultrasound guidance support, a digital platform for patient-specific 3D reconstructions, and a data and analytics module for post-procedural analysis.

Product and service1 record
1LARC Robot
CategorySurgical Robotics / Urology Medical Devices
Description

A table-mounted miniature surgical robotic device for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures. It enables intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion, and is CE-marked and FDA-cleared for 2D and 3D image-guided procedures. Intended for hospitals, healthcare facilities, and urologists performing kidney stone removal surgery.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LARC Robotics LLC is part of the iSYS Medizintechnik GmbH group. The company was founded as a spin-off of Interventional Systems (Austria-based company) and leverages their years of expertise, products, and know-how in the complex interventional radiology landscape.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Urology-focused robotic surgery company (Aquablation) targeting BPH and expanding across urological indications. Most directly comparable in being a surgical robotics company selling capital equipment to urology departments at hospitals.

TypeBroad incumbent
Description

Incumbent da Vinci surgical robotics platform used across urology (including kidney and PCNL procedures). Broad incumbent with overlapping capability and the installed base against which single-indication entrants must compete.

TypeDirect peer
Description

Developer of the Versius surgical robotic system, a modular, multi-port platform marketed to hospitals including for urology. Direct peer as a general-purpose surgical robotics company competing for the same hospital capital budgets.

TypeBroad incumbent
Description

Hugo RAS robotic-assisted surgery platform extends Medtronic's broad medtech portfolio into surgical robotics, including urology. Broad incumbent with overlapping urology access.

TypeBroad incumbent
Description

Mako robotic surgery platform and large installed base in orthopedics, with adjacent surgical robotics efforts relevant to capital equipment procurement decisions LARC faces at hospitals.

TypeDirect peer
Description

European surgical robotics company specifically targeting urology and laparoscopic procedures. Direct peer in single-specialty robotic surgery for urology hospitals.

TypeEmerging player
Description

Emerging surgical robotics company building a table-side, AI-assisted robotic platform for laparoscopic surgery. Comparable emerging player in surgical robotics targeting hospital OR workflows.

TypeEmerging player
Description

Medical robotics business focused on neurosurgical and implantable device applications, sharing the heritage of a precision-engineering company entering surgical robotics as an adjacent category.

TypeOthers
Description

Long-established endoscopy and urology instrumentation company supplying PCNL and ureteroscopy equipment to the same hospital urology departments LARC targets. Adjacent competitor on the buying-committee level, though not a robotic platform.

TypeOthers
Description

Specialist urology/surgical equipment maker with a strong installed base in PCNL and endourology instruments. Adjacent equipment competitor and ecosystem participant in the same hospital urology suites.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

larc robotics

Surgical Roboticslarc-robotics.com

LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic platform for image-guided renal access during percutaneous nephrolithotomy (PCNL) kidney stone procedures, serving urologists and hospitals.

What larc robotics does

LARC Robotics LLC is a privately held medical device company headquartered at 535 5th Ave 4th floor in New York, NY, that develops the LARC Robot, a table-mounted miniature surgical robotic platform designed specifically for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures used to treat kidney stones. The platform combines intraoperative planning, real-time imaging targeting, and robotic-assisted needle insertion, and is CE-marked and FDA-cleared for both 2D and 3D image-guided procedures. Its primary value proposition is enabling urologists to perform renal access independently without reliance on interventional radiologists, addressing technical complexity, operative time, radiation exposure, and scheduling dependencies that the company cites as the main drivers of PCNL's roughly 7% adoption rate among kidney stone procedures.

The company is a spin-off of Austria-based Interventional Systems and operates as part of the iSYS Medizintechnik GmbH group, inheriting domain expertise and product know-how in interventional radiology. Its commercial model is a direct-sales approach to hospitals and healthcare facilities performing urology procedures, consistent with enterprise capital-equipment procurement; pricing is not publicly disclosed and is presumed to be quote-based. GTM channels are predominantly clinical-scientific in nature, including LinkedIn, Twitter, YouTube (surgical session and conference content), email newsletters, and industry-conference presentations such as LSI Europe 2024.

The product roadmap extends the single hardware product with planned 2D-fluoroscopic navigation and ultrasound guidance support, a digital platform for patient-specific 3D reconstructions of diagnostic scans, and a post-procedural data and analytics module. The company is GDPR-compliant, maintains a small public footprint, and has no disclosed revenue, headcount, funding rounds, or named hospital customers in the source material.

larc robotics firmographics

Firmographics
Name
larc robotics
Legal name
LARC Robotics LLC
Website
https://larc-robotics.com
Company type
Private
Operating status
Operating
Short description
LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic platform for image-guided renal access during percutaneous nephrolithotomy (PCNL) kidney stone procedures, serving urologists and hospitals.
Ownership category
akta.pro rank

larc robotics industry classification

Industry
Product category
Surgical Robotics
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
akta.pro secondary industry
Healthcare & Assistive Robotics (HDAAAIAC)

Keywords

  • Surgical robotics systems
  • Image-guided surgery
  • Renal access devices
  • Percutaneous nephrolithotomy equipment
  • Medical robotics platform

Where larc robotics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

larc robotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Distribution channels1 record

Marketing channels5 records

larc robotics product offering

Product offering

Core offering

LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic device designed for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures. The platform combines intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion to allow urologists to independently establish renal access for kidney stone removal without relying on interventional radiologists. The technology is cleared for both 2D and 3D image-guided procedures.

Product overview

LARC Robotics offers a single unified surgical robotic platform called the LARC Robot, designed specifically for percutaneous nephrolithotomy (PCNL) procedures to treat kidney stones. The platform is a table-mounted miniature device that provides intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion. The company is also developing future capabilities including 2D-fluoro navigation and ultrasound guidance support, a digital platform for patient-specific 3D reconstructions, and a data and analytics module for post-procedural analysis.

Differentiator

Problem solved

Functional benefit

Products and services

  • LARC Robot A table-mounted miniature surgical robotic device for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures. It enables intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion, and is CE-marked and FDA-cleared for 2D and 3D image-guided procedures. Intended for hospitals, healthcare facilities, and urologists performing kidney stone removal surgery.

Quantifiable outcome

  • PCNL is the technique with the highest stone-free rate and best chance for single-surgery treatment
  • +1 more outcomes

Companies that use larc robotics

Customer profile

Segments2 records

Ideal customer profiles1 record

larc robotics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

larc robotics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • iSYS Medizintechnik GmbH groupcoreStrategic or Co-development PartnerLARC Robotics LLC is part of the iSYS Medizintechnik GmbH group. The company was founded as a spin-off of Interventional Systems (Austria-based company) and leverages their years of expertise, products, and know-how in the complex interventional radiology landscape.

Recent moves6 records

Expansion highlights5 records

larc robotics competitors and assessment

Company assessment

Direct peers

  • PROCEPT BioRobotics: Urology-focused robotic surgery company (Aquablation) targeting BPH and expanding across urological indications. Most directly comparable in being a surgical robotics company selling capital equipment to urology departments at hospitals.
  • CMR Surgical: Developer of the Versius surgical robotic system, a modular, multi-port platform marketed to hospitals including for urology. Direct peer as a general-purpose surgical robotics company competing for the same hospital capital budgets.
  • Avatera Medical: European surgical robotics company specifically targeting urology and laparoscopic procedures. Direct peer in single-specialty robotic surgery for urology hospitals.

Broad incumbents

  • Intuitive Surgical: Incumbent da Vinci surgical robotics platform used across urology (including kidney and PCNL procedures). Broad incumbent with overlapping capability and the installed base against which single-indication entrants must compete.
  • Medtronic: Hugo RAS robotic-assisted surgery platform extends Medtronic's broad medtech portfolio into surgical robotics, including urology. Broad incumbent with overlapping urology access.
  • Stryker: Mako robotic surgery platform and large installed base in orthopedics, with adjacent surgical robotics efforts relevant to capital equipment procurement decisions LARC faces at hospitals.

Emerging players

  • Moon Surgical: Emerging surgical robotics company building a table-side, AI-assisted robotic platform for laparoscopic surgery. Comparable emerging player in surgical robotics targeting hospital OR workflows.
  • Renishaw: Medical robotics business focused on neurosurgical and implantable device applications, sharing the heritage of a precision-engineering company entering surgical robotics as an adjacent category.

Others

  • Karl Storz: Long-established endoscopy and urology instrumentation company supplying PCNL and ureteroscopy equipment to the same hospital urology departments LARC targets. Adjacent competitor on the buying-committee level, though not a robotic platform.
  • Richard Wolf: Specialist urology/surgical equipment maker with a strong installed base in PCNL and endourology instruments. Adjacent equipment competitor and ecosystem participant in the same hospital urology suites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

larc robotics social profiles

Digital presence

larc robotics compliance and trust

Trust signal

Compliance3 records

larc robotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

larc robotics leadership team

Management profile

Number of profiles

larc robotics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

larc robotics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about larc robotics

What does larc robotics do?

LARC Robotics develops the LARC Robot, a CE-marked and FDA-cleared table-mounted miniature surgical robotic device designed for image-guided renal access during percutaneous nephrolithotomy (PCNL) procedures. The platform combines intraoperative planning, real-time imaging targeting, and precise robotic-assisted needle insertion to allow urologists to independently establish renal access for kidney stone removal without relying on interventional radiologists. The technology is cleared for both 2D and 3D image-guided procedures.

Is larc robotics a public or private company?

larc robotics is a private company. It is classified as corporate owned and is currently operating.

When was larc robotics founded?

larc robotics was founded in -1.

Where is larc robotics based?

larc robotics is headquartered in New York, United States, in the North America region.

Who are larc robotics's main competitors?

Direct peers on record are PROCEPT BioRobotics, CMR Surgical and Avatera Medical. Broad incumbents are Intuitive Surgical, Medtronic and Stryker. Emerging players are Moon Surgical and Renishaw. Others are Karl Storz and Richard Wolf.

Does larc robotics have an API?

No public API is recorded for larc robotics.

What industry is larc robotics in?

larc robotics's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales